Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–17 of 17 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT07128381
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia (CMML), +14 more
- Locations
-
- The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States
Recruiting
Thiotepa-Containing Conditioning Regimen for Allogeneic HSCT in Chronic Myelomonocytic Leukemia
NCT07588594
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia (CMML), +11 more
- Locations
-
- Peking University People's Hospital Beijing, China
- Conditions
- AML (Acute Myelogenous Leukemia), Acute Leukemia (Category), Acute Lymphoid Leukemia (ALL), +36 more
- Locations
-
- University of Alabama Birmingham Birmingham, Alabama, United States
- City of Hope Duarte, California, United States
- Stanford Palo Alto, California, United States
- University of Miami Miami, Florida, United States
NCT06994676
- Conditions
- AML - Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +17 more
- Locations
-
- City of Hope Duarte, California, United States
- Stanford Medical Center Palo Alto, California, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Northwestern Medicine Chicago, Illinois, United States
Recruiting
A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
NCT06950034
- Conditions
- Acute Monocytic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), +24 more
- Locations
-
- Stanford University Stanford, California, United States
- Moffitt Tampa, Florida, United States
- DFCI Boston, Massachusetts, United States
- Mayo Clinic Rochester, Minnesota, United States
Not Yet Recruiting
TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
NCT07302776
- Conditions
- Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +21 more
- Locations
-
- Stanford University Palo Alto, California, United States
Not Yet Recruiting
The Kinetics Profiling of Immune Reconstitution and Clinical Outcomes
NCT07113730
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia (CMML), +12 more
- Locations
-
Not specified
NCT05665530
- Conditions
- Acute Myeloid Leukemia (AML), Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL), Bone Marrow Diseases, +41 more
- Locations
-
- City of Hope Duarte, California, United States
- American Oncology Partners of Maryland, PA Bethesda, Maryland, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health New York, United States
NCT05048498
- Conditions
- Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +15 more
- Locations
-
- Karolinska University Hospital Huddinge Huddinge, Sweden
- Kliniska Forsknings och Utvecklings Enheten KFUE Uppsala, Sweden
NCT01736683
- Conditions
- Anemia, Bone Marrow Diseases, Chronic Disease, +16 more
- Locations
-
- Rocky Mountain Cancer Center-Midtown Denver, Colorado, United States
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Johns Hopkins Baltimore, Maryland, United States
- Dana-Farber / Harvard Cancer Institute Boston, Massachusetts, United States
NCT01842646
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia (CMML), +13 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
NCT01613976
- Conditions
- Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +15 more
- Locations
-
- Novartis Investigative Site Nagoya, Aichi-ken, Japan
- Novartis Investigative Site Nagoya, Aichi-ken, Japan
- Novartis Investigative Site Kobe, Hyōgo, Japan
- Novartis Investigative Site Sendai, Miyagi, Japan
Completed
Study of Lenzilumab in Previously Treated Patients With Chronic Myelomonocytic Leukemia (CMML)
NCT02546284
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia (CMML), +11 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- Mayo Clinic Cancer Center Clinical Research Rochester, Minnesota, United States
NCT00528983
- Conditions
- Acute Myelogenous Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +16 more
- Locations
-
- University of Florida Gainesville, Florida, United States
- University of Chicago Medical Center Chicago, Illinois, United States
- Central Indiana Cancer Centers Indianapolis, Indiana, United States
- Kansas University Medical Center Westwood, Kansas, United States
Active, Not Recruiting
Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations
NCT04603001
- Conditions
- Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +17 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- UCLA Medical Center Los Angeles, California, United States
- University of California, Davis - Health Systems Sacramento, California, United States
- H Lee Moffitt Cancer Center Tampa, Florida, United States
Active, Not Recruiting
Cobimetinib in Newly Diagnosed or HMA-treated CMML Patients With RAS Pathway Mutations
NCT04409639
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia (CMML), +11 more
- Locations
-
- Oregon Health and Science University Portland, Oregon, United States
- Huntsman Cancer Institute at University of Utah Salt Lake City, Utah, United States
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
Active, Not Recruiting
Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN
NCT03613532
- Conditions
- Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +17 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States